testosterone safety

As always, well said by our Dr. Khera: Mohit Khera, MD, MBA, MPH, on why TRT should not be a Schedule III controlled substance

Efficacy and safety of testosterone replacement therapy in men with hypogonadism: A meta-analysis study of placebo-controlled trials Abstract The purpose of the present meta-analysis was to evaluate the efficacy and safety of testosterone replacement therapy in men with hypogonadism. A search...

Safety of T Therapy in Older Men The use of T therapies in older men has been limited by concerns over adverse cardiovascular and prostatic effects. Several meta-analyses suggest T has been well-tolerated in the majority of studies in healthy older men. [141],[142],[143] The most frequent...